FNCRX
Price
$41.69
Change
+$0.29 (+0.70%)
Updated
Jul 13 closing price
Net Assets
487.82M
TRNEX
Price
$46.27
Change
+$0.05 (+0.11%)
Updated
Jul 13 closing price
Net Assets
2.77B
Interact to see
Advertisement

FNCRX vs TRNEX

FNCRX vs TRNEX Comparison Chart in %
View a ticker or compare two or three
VS
FNCRX vs. TRNEX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNCRX is a Buy and TRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.77B vs. FNCRX (488M). TRNEX pays higher dividends than FNCRX: TRNEX (2.39) vs FNCRX (0.92). FNCRX was incepted earlier than TRNEX: FNCRX (21 years) vs TRNEX (11 years). FNCRX (1.76) is less costly to investors than TRNEX (0.57). TRNEX is a more actively managed with annual turnover of: 38.60 vs. FNCRX (19.72). FNCRX has a lower initial minimum investment than TRNEX: FNCRX (1000) vs TRNEX (500000). FNCRX annual gain was more profitable for investors over the last year : 35.68 vs. TRNEX (17.12). FNCRX return over 5 years is better than : 114.06 vs. TRNEX (42.26).
FNCRXTRNEXFNCRX / TRNEX
Total Expense Ratio1.750.57307%
Annual Report Gross Expense Ratio1.760.57309%
Fund Existence21 years11 years-
Gain YTD15.96614.236112%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets488M2.77B18%
Annual Yield % from dividends0.922.3938%
Returns for 1 year35.6817.12208%
Returns for 3 years53.3120.46260%
Returns for 5 years114.0642.26270%
Returns for 10 years76.0472.15105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.79N/A
+0.28%
Innate Pharma SA
PJT157.130.21
+0.13%
PJT Partners
INMD15.15-0.13
-0.85%
InMode Ltd
MLM569.35-8.37
-1.45%
Martin Marietta Materials
PBM2.85-0.12
-4.04%
Psyence Biomedical Ltd.